Browse diseases

… in SAFE score corresponded to a 0.05-point increase in 10-year ASCVD risk, B=0.05, SE=0.005, p<0.001 (figure 1D). The findings sugge…

…) and excess weight (BMI) both associate with increased risk of hepatic steatosis: risk ratios (RR) 9.3 (95% CI 6.4 to 13.6) and 8.8 (95% CI 5.8 …

…neal administration of IgG on HFD-fed mice markedly exacerbated hepatic steatosis and histopathological injury relative to the vehicle-treated HF…

…, monitoring, and treatment needs to be established. Given that MASLD is a multisystem disease, assessing cost effectiveness should c…

…setting of established metabolic disorders, such as obesity and type 2 diabetes mellitus. MASLD is a complex and multifactorial condition for which nume…

…kin-6; LN, laminin; LDL-C, low-density lipoprotein cholesterol; MASLD, metabolic dysfunction-associated steatotic liver disease; PC I…

…698; PMCID: PMC7614852.Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk f…

…Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory progression to metabolic dysfuncti…

…R: 1.6, 95%CI: 1.3-2.1, I2=0%) (IDDF2026-ABS-0087 Figure 3) and hepatocellular carcinoma (OR: 1.8, 95%CI: 1.3-2.6, I2= 0%) (IDDF2026-ABS-0087 Figure 4) …

…cts against hepatic steatosis, yet its endogenous regulation in Metabolic dysfunction-associated fatty liver disease (MAFLD) remains elusive. This study investigates the clinical significa…

…tic liver disease (MASLD) is an increasingly prevalent cause of chronic liver disease, closely linked with obesity, diabetes, and other metabolic ris…

…One in five young adults in the UK already has fatty-liver disease. In the Avon Longitudinal Study of Parents and Children (ALSPAC…